Carregant...
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
BACKGROUND: There is no established treatment of AA amyloidosis, a long-term complication of various chronic inflammatory diseases associated with increased mortality, such as familial Mediterranian fever (FMF). Recently there are few reports pointing out that tocilizumab(TCZ), an anti IL-6 agent ma...
Guardat en:
| Publicat a: | Orphanet J Rare Dis |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5450086/ https://ncbi.nlm.nih.gov/pubmed/28558744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-017-0642-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|